A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF inhibitor therapy for metastatic melanoma

Dermatol Surg. 2013 Feb;39(2):341-4. doi: 10.1111/dsu.12035. Epub 2012 Dec 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Fluorouracil / therapeutic use
  • Humans
  • Indoles / adverse effects*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / surgery
  • Mohs Surgery
  • Neoplasm Invasiveness
  • Photochemotherapy
  • Proto-Oncogene Proteins B-raf
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Skin Neoplasms / therapy*
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Antimetabolites, Antineoplastic
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Fluorouracil